This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Preeti G Desai: Innovator in Antibody Formulations
Introduction
Preeti G Desai is a prominent inventor based in Westfield, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations. With a total of 2 patents, her work focuses on innovative solutions for treating various disorders.
Latest Patents
Desai's latest patents include co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies. The present invention provides co-formulations of these antibodies, which are crucial for treating various disorders. Additionally, she has developed formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies, further enhancing therapeutic options in the medical field.
Career Highlights
Preeti G Desai is associated with Merck Sharp & Dohme Corporation, where she applies her expertise in antibody research and development. Her work has been instrumental in advancing the understanding and application of antibody therapies.
Collaborations
Desai collaborates with notable colleagues such as Valentyn Antochshuk and Yogita Krishnamachari, contributing to a dynamic research environment that fosters innovation.
Conclusion
Preeti G Desai's contributions to antibody formulations represent a significant advancement in biotechnology. Her innovative work continues to pave the way for new treatments and therapies in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile